Skip to main content

Search

Reset all filters
109 Result(s)
Sort by

Oncology Translational Science

Oncology Translational Science

Discover how Boehringer Ingelheim leverages translational science to bridge pre-clinical research and clinical development, enhancing patient outcomes in oncology. Learn about our patient-centric strategies, biomarker discovery, and collaborative efforts
Retinal Diseases

Retinal Diseases

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases, specifically those affecting the back of the eye.
Immune cell directed therapies

Immune cell directed therapies

Boehringer Ingelheim is committed to transforming cancer care, investigating therapies that target cancer cells and boost the immune system for the benefit of patients.
Computational Biology & Digital Sciences

Computational Biology & Digital Sciences

At Boehringer Ingelheim, we are investing into the power of computational biology and data sciences to accelerate the journey from scientific discoveries to breakthrough therapies.
Code of Conduct

Code of Conduct

Our Code of Conduct sets the ethical standards that guides all our business activities. It´s about all of us. Each individual plays a vital role in bringing the Code of Conduct to live.
Small Molecule Drug Discovery

Small Molecule Drug Discovery

Boehringer Ingelheim scientists continue to expand the horizons of what small molecule drugs can achieve.
Research at Regional Center Vienna

Research at Regional Center Vienna

RCV is the regional affiliate of Boehringer Ingelheim and responsible for over 30 countries in Central and Eastern Europe and Central Asia.
Health, Safety & Environment

Health, Safety & Environment

Suppliers aim to ensure a safe and healthy working environment and to act in an ecological and sustainable manner.
Drug discovery Boehringer Ingelheim

Drug discovery Boehringer Ingelheim

Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.